Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine
Product Description
Yuxi Walvax Biotechnology Co., Ltd.
-
Country/Region:China
-
On CPHI since:2023
-
Employees:1000 - 4999
Company types
Categories
Yuxi Walvax Biotechnology Co., Ltd.
-
Country/Region:China
-
On CPHI since:2023
-
Employees:1000 - 4999
Company types
More Products from Yuxi Walvax Biotechnology Co., Ltd. (2)
-
Product 13-valent Pneumococcal Polysaccharide Conjugate Vaccine
To prevent invasive diseases caused by 13 serotypes of Streptococcus pneumoniae in infants and children 6 weeks through 5 years of age (before the 6th birthday) -
Product 23-valent Pneumococcal Polysaccharide Vaccine
To prevent invasive diseases caused by 23 serotypes of Streptococcus pneumoniae for use in individuals aged ≥ 2 years who are at increased risk of pneumococcal diseases